Brief: Lee's Pharmaceutical Reports Qtrly Profit Attributable HK$34.2 Mln
17/11/2022 10:21
Nov 17 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* QTRLY PROFIT ATTRIBUTABLE HK$34.2 MILLION VERSUS HK$13.8
MILLION
* QTRLY REVENUE HK$387.0 MILLION VERSUS HK$368.3 MILLION
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA